Harvest Fund Management Co. Ltd Purchases 5,984 Shares of Doximity, Inc. (NASDAQ:DOCS)

Harvest Fund Management Co. Ltd increased its position in Doximity, Inc. (NASDAQ:DOCS) by 197.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,020 shares of the company’s stock after buying an additional 5,984 shares during the period. Harvest Fund Management Co. Ltd’s holdings in Doximity were worth $393,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. LRI Investments LLC bought a new stake in Doximity in the 1st quarter worth approximately $27,000. Farther Finance Advisors LLC increased its position in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the last quarter. Blue Trust Inc. raised its stake in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP lifted its position in Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Doximity in the 1st quarter worth $46,000. 87.19% of the stock is owned by institutional investors.

Doximity Stock Performance

Doximity stock opened at $53.54 on Wednesday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company has a market capitalization of $10.00 billion, a PE ratio of 61.54, a P/E/G ratio of 3.91 and a beta of 1.30. The company has a 50 day moving average price of $44.83 and a 200-day moving average price of $35.34.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of analyst reports. The Goldman Sachs Group began coverage on shares of Doximity in a report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price target for the company. Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and lifted their target price for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. Bank of America increased their price target on Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Robert W. Baird lifted their price objective on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 17th. Finally, Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research report on Friday, August 9th. Eleven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity has an average rating of “Hold” and an average target price of $52.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.